ClinicalTrials.Veeva

Menu

COVID-19: Early Detection of Worsening by Voice and Respiratory Pattern Characteristics (COVOICE)

D

Direction Centrale du Service de Santé des Armées

Status

Enrolling

Conditions

COVID-19
Sars-CoV-2 Infection

Treatments

Device: COVOICE application use - follow-up
Device: COVOICE application use - initial

Study type

Observational

Funder types

Other

Identifiers

NCT05892549
2020-COVID19-21
2020-A03182-37 (Other Identifier)

Details and patient eligibility

About

In some clinical forms of COVID-19, an uncontrolled hyper-inflammatory reaction known as a "cytokine storm" appears abruptly, around day 7, and is associated with rapid respiratory deterioration, requiring hospitalization in an intensive care unit (ICU).

At present, although risk factors for this severe form have been described, there are no validated criteria for determining which individual patients will develop this aggravation.

The study of respiratory sounds (amplitude, frequency, ...) has made it possible in other respiratory pathologies (e.g., chronic obstructive pulmonary disease) to predict exacerbations several days in advance.

Having a predictive respiratory pattern for worsening in COVID-19 would make it possible to anticipate the need for intensive care hospital beds, by means of a tool easily available on a mobile phone.

Enrollment

1,188 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • French speaking
  • Affiliated to a social security system
  • Owning a mobile phone capable of accessing the COVOICE application

Exclusion criteria

  • Incapable adults
  • People deprived of their liberty
  • People under administrative or judicial supervision
  • Patients intubated or hospitalized in intensive care unit

Trial design

1,188 participants in 3 patient groups

COVID
Treatment:
Device: COVOICE application use - follow-up
Other respiratory diseases
Treatment:
Device: COVOICE application use - follow-up
Healthy
Treatment:
Device: COVOICE application use - initial

Trial contacts and locations

1

Loading...

Central trial contact

Hubety NIELLY, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems